Hepion Pharmaceuticals Statistics Share Statistics Hepion Pharmaceuticals has 10.98M
shares outstanding. The number of shares has increased by -89.82%
in one year.
Shares Outstanding 10.98M Shares Change (YoY) -89.82% Shares Change (QoQ) -89.99% Owned by Institutions (%) 9.38% Shares Floating 10.14M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 110.86K, so 1.01% of the outstanding
shares have been sold short.
Short Interest 110.86K Short % of Shares Out 1.01% Short % of Float 1.01% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.22 and the forward
PE ratio is null.
Hepion Pharmaceuticals's PEG ratio is
0.
PE Ratio -0.22 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio -1.55 P/FCF Ratio -0.16 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Hepion Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.51,
with a Debt / Equity ratio of -1.56.
Current Ratio 0.51 Quick Ratio 0.51 Debt / Equity -1.56 Debt / EBITDA -0.15 Debt / FCF -0.16 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-599.66K Employee Count 22 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -2.97M Effective Tax Rate 18.37%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 1.55, so Hepion Pharmaceuticals's
price volatility has been higher than the market average.
Beta 1.55 52-Week Price Change n/a 50-Day Moving Average 0.27 200-Day Moving Average 18.3 Relative Strength Index (RSI) 23.42 Average Volume (20 Days) n/a
Income Statement
Revenue n/a Gross Profit n/a Operating Income -19.35M Net Income -13.19M EBITDA -19.35M EBIT -17.41M Earnings Per Share (EPS) -107.35
Full Income Statement Balance Sheet The company has 406.41K in cash and 2.9M in
debt, giving a net cash position of -2.49M.
Cash & Cash Equivalents 406.41K Total Debt 2.9M Net Cash -2.49M Retained Earnings -237.82M Total Assets 1.61M Working Capital -1.53M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -18.22M
and capital expenditures 0, giving a free cash flow of -18.22M.
Operating Cash Flow -18.22M Capital Expenditures n/a Free Cash Flow -18.22M FCF Per Share -148.23
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields HEPA does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for HEPA.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Mar 18, 2025. It was a
backward
split with a ratio of 1:50.
Last Split Date Mar 18, 2025 Split Type backward Split Ratio 1:50
Scores Altman Z-Score -239.14 Piotroski F-Score 0
